Digestive disorders are observed in 20 million Canadians every year. Moreover, it costs 18 bn dollars to the Canadian economy in terms of medical expenses and loss of productivity. Nucliq Biologics I...
Nucliq Biologics Inc.
8 enregistrements totalisant 695,923.00 $ CAN, selon les données ouvertes officielles du gouvernement du Canada.
Intégrer ce graphique
Par ministère
| Conseil national de recherches Canada | $695,923 | 8 enregistrements |
Enregistrements
NBI performs tests to uncover the gut microbiome and provides a detailed clinical report and counselling related to gut health, food, nutrition and bacterial composition to improve patient’s health. T...
The human microbiome extends beyond the gut, with vaginal and oral microbial ecosystems playing vital roles in systemic and reproductive health. Nucliq Biologics, through its flagship platform Gutchec...
This project advances microbiome testing through 2 additional assessment products and metadata evaluation for drug discovery. This initiative strengthens microbiome analysis, personalized health insig...
Digestive disorders are observed in 20 million Canadians every year. Moreover, it costs 18 bn dollars to the Canadian economy. Nucliq Biologics Inc (NBI) incorporated in April 2019 provides services t...
Nucliq Biologics Inc. is a St John’s, NL- based biotechnology company leveraging its knowledge of molecular and functional interactions between the microbiome and the human body to understand and deve...
Improve B2B partner requirements (including fungal and parasite detection) and to expand the customer base to include younger customers by establishing an enhanced set of tests in the lab. These ac...
This project will increase automation in the order processing pipeline, thereby leading to higher efficiencies and reduced risks.